Bosflex
A trademarked form of Boswellia Serrata
Bosflex is VitaActives' Boswellia serrata extract standardised to 10% AKBA. No brand-specific clinical trials are indexed yet; evidence shown relates to the parent ingredient.
Manufacturer
VitaActives
Clinical Studies
0
Certifications
0
Purity
10% AKBA
Last reviewed: 2026-10-06
What Makes It Different
Boswellia standardised to 10% AKBA, the key 5-LOX-inhibiting boswellic acid.
Technical Specifications
Ingredient Type
Boswellia serrata resin extract
Purity / Standardisation
10% AKBA
Brand Owner
VitaActives
Country of Origin
United Kingdom
Frequently Asked Questions
What is Bosflex?
Bosflex is a trademarked form of Boswellia Serrata manufactured by VitaActives. Bosflex is VitaActives' Boswellia serrata extract standardised to 10% AKBA. No brand-specific clinical trials are indexed yet; evidence shown relates to the parent ingredient.
How is Bosflex different from generic Boswellia Serrata?
Boswellia standardised to 10% AKBA, the key 5-LOX-inhibiting boswellic acid.
Who makes Bosflex?
Bosflex is made by VitaActives (United Kingdom).
How much clinical evidence does Bosflex have?
SuppIndex lists 0 clinical studies for Bosflex. The parent ingredient Boswellia Serrata has an overall evidence score of 40/100 (Limited).
Parent Ingredient
Boswellia Serrata
Boswellic acids inhibit 5-lipoxygenase (5-LOX), reducing leukotriene synthesis. Several RCTs in knee osteoarthritis using extracts standardised to AKBA report symptom improvements versus placebo over 1–3 months.
View the parent ingredient page for full evidence review, dosage guidance, mechanism of action, and safety information.
Manufacturer
VitaActives
United Kingdom
Visit WebsiteCompare
See how Bosflex compares to other forms or the generic version.
Open Comparison